Felix Huth
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Pharmacogenetics and Drug Metabolism, Chronic Myeloid Leukemia Treatments, Occupational and environmental lung diseases, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective(2018)354 cited
- → Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats(1987)268 cited
- → Physiologically‐Based Pharmacokinetic Models for Evaluating Membrane Transporter Mediated Drug–Drug Interactions: Current Capabilities, Case Studies, Future Opportunities, and Recommendations(2019)139 cited
- → Tumorigenic effect of fibrous dust in experimental animals(1974)84 cited
- → Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake: In Silico and Clinical Evaluations(2017)78 cited
- Carcinogenicity studies on natural and man-made fibres with the intraperitoneal test in rats.(1989)
- → Characterization of Surfactin-like Cyclic Depsipeptides Synthesized by Bacillus pumilus from Ascidian Halocynthia aurantium(2002)